Executive Summary
F.Hoffmann-La Roche Ag filed a Transfer Civil Miscellaneous Appeal (Patents) challenging an earlier decision by the Controller of Patents and Designs concerning Patent No. 207232. The appellant subsequently instructed counsel to withdraw the appeal due to the expiry of the patent term.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in F.Hoffmann-La Roche Ag vs The Controller of Patents and Designs, Government of India is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
J. Nageswara RaovsThe State Of Madras
The petitioner challenged the classification of his patented medicine, 'Vitogen', as 'medicated wine' and the associated duties levied under the Madras Prohibition Act. The court examined the scope of the Act and various notifications regarding medicinal preparations. While upholding the liability of 'Vitogen' to pay a specific duty (Rs. 35 per proof gallon) under Notification No. 473, the court declared certain provisions of the Act, including Section 23(2) and Notification No. 941, as ultra vires and unenforceable.
Ms Allanasons Private LimitedvsThe Registrar Of Trademarks & Anr.
The Delhi High Court issued an order in the matter concerning Ms Allanasons Private Limited versus The Registrar Of Trademarks & Anr. This interim order scheduled both associated commercial IP disputes (C.O. (COMM.IPD-TM) 86/2024 and C.O. (COMM.IPD-TM) 91/2024) for a hearing on August 29, 2025. The court's directive indicates the ongoing procedural progression of these trademark matters.
Voicemonk IncvsController General of Patents, Designs & Trade Marks
Voicemonk Inc appealed the rejection of its patent application for a system and method related to content recommendation using Augmented Reality. The Controller had raised objections regarding lack of clarity, subject matter eligibility (Section 3(k)), and novelty/inventiveness (Sections 2(1)(j) and 10(4)).
Immunovative Therapies Ltd.vsThe Controller Of Patents
Immunovative Therapies Ltd. appealed a rejection order dated December 4, 2018, concerning its patent application for 'TH1 VACCINATION PRIMING FOR ACTIVE IMMUNOTHERAPY'. The appellant argued that the rejection based on Section 3(d) and (i) was incorrect, as the invention relates to therapeutic vaccine methods using allogeneic CD3/CD28 cross-linked Thl memory cells.
Microsoft Technology Licensing LlcvsThe Assistant Controller Of Patents And Designs
Microsoft Technology Licensing Llc filed an appeal challenging the Patent Office's order rejecting its application titled "DISCOVERY OF SECURE NETWORK ENCLAVES". The rejection was based on grounds related to Sections 2(l)(j) and Section 10(4) of the Patents Act, 1970. The court released the matter from part-heard status and listed it for further hearing.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.